Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: An immunohistochemical and fluorescence in situ hybridization study

Cancer

Volumn 103, Issue 6, 2005, Pages 1265-1273

  Suzuki, Shioto ^a   Dobashi, Yoh ^a   Sakurai, Hiroyuki ^a   Nishikawa, Keiichi ^a   Hanawa, Mitsuhiko ^a   Ooi, Akishi ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Epidermal growth factor receptor; Fluorescence in situ hybridization; Metastasis; Nonsmall cell lung carcinomas

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; RECEPTOR ANTIBODY;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GENETICS; CANCER STAGING; CLINICAL FEATURE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC CORRELATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RISK ASSESSMENT; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 14744281693     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20909     Document Type: Article

References (40)

1. Wrann MM, Fox CF. Identification of epidermal growth factor receptors in a hyperproducing human epidermoid carcinoma cell line. J Biol Chem. 1979;254:8083-8086.
2. Lin CR, Chen WS, Kruiger W, et al. Expression cloning of human EGF receptor complementary DNA: gene amplification and three related messenger RNA products in A431 cells. Science. 1984;224:843-848.
3. Nicholson RI, Gee JM, Harper ME. EGFR and cancer prognosis. Eur J Cancer. 2001;37(Suppl 4):9-15.
4. Brabender J, Danenberg KD, Metzger R, et al. Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer is correlated with survival. Clin Cancer Res. 2001;7:1850-1855.
5. Franklin WA, Veve R, Hirsch FR, Helfrich BA, Bunn PA Jr. Epidermal growth factor receptor family in lung cancer and premalignancy. Semin Oncol. 2002;29:3-14.
6. Sauter G, Maeda T, Waldman FM, Davis RL, Feuerstein BG. Patterns of epidermal growth factor receptor amplification in malignant gliomas. Am J Pathol. 1996;148:1047-1053.
7. Ishitoya J, Toriyama M, Oguchi N, et al. Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck. Br J Cancer. 1989;59:559-562.
8. Reinmuth N, Brandt B, Kunze WP, et al. Ploidy, expression of erbB1, erbB2, P53 and amplification of erbB1, erbB2 and erbB3 in non-small cell lung cancer. Eur Respir J. 2000;16:991-996.
9. Platzer P, Upender MB, Wilson K, et al. Silence of chromosomal amplifications in colon cancer. Cancer Res. 2002;62:1134-1138.
10. Lemoine NR, Hughes CM, Barton CM, et al. The epidermal growth factor receptor in human pancreatic cancer. J Pathol. 1992;166:7-12.
11. Moch H, Sauter G, Gasser TC, et al. EGF-r gene copy number changes in renal cell carcinoma detected by fluorescence in situ hybridization. J Pathol. 1998;184:424-429.
12. Takehana T, Kunitomo K, Suzuki S, et al. Over-expression of epidermal growth factor receptor in gastric carcinomas is rare but occurs predominantly by gene amplification. Clin Gastroenterol Hepatol 2003;1:438-445.
13. Ooi A, Takehana T, Li X, et al. Protein overexpression and gene amplification of HER-2 and EGFR in colorectal cancers: an immunohistochemical and fluorescent in situ hybridization study. Mod Pathol. 2004;17:895-904.
14. Dobashi Y, Takei N, Suzuki S, et al. Aberration of epidermal growth factor receptor expression in bone and soft-tissue tumors: protein overexpression, gene amplification and activation of downstream molecules. Mod Pathol 2004;17:1497-1505.
15. Hirsch FR, Varella-Garcia M, Bunn PA Jr., et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol. 2003;21:3798-3807.
16. U.S. Food and Drug Administration (FDA). FDA approves Erbitux for colon cancer. FDA News. Available from URL: http://www.fda.gov/bbs/topics/NEWS/2004/ NEW0/024. html [accessed 7 February 2005].
17. Cohen MH, Williams GA, Sridhara R, Chen G, Pazdur R. FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets. Oncologist. 2003;8:303-306.
18. Huang SM, Li J, Armstrong EA, Harari PM. Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa). Cancer Res. 2002;62:4300-4306.
19. Fleming ID, Cooper JS, Hensen DE, et al, editors. AJCC cancer staging manual, 5th ed. Philadelphia: Lippincott-Raven, 1998.
20. Travis WD, Colby TV, Travis WD. Histological typing of lung and pleural tumors. 3rd ed. New York: Springer-Verlag, 1999.
21. Kitayama Y, Igarashi H, Sugimura H. Initial intermittent microwave irradiation for fluorescence in situ hybridization analysis in paraffin-embedded tissue sections of gastrointestinal neoplasia. Lab Invest. 2000;80:779-781.
22. Takehana T, Kunitomo K, Kono K, et al. Status of c-erbB-2 in gastric adenocarcinoma: a comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay. Int J Cancer. 2002;98:833-837.
23. Pauletti G, Dandekar S, Kong H, et al. Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry. J Clin Oncol. 2000;18:3651-3664.
24. Kobayashi M, Ooi A, Oda Y, Nakanishi I. Protein overexpression and gene amplification of c-erbB-2 in breast carcinomas: a comparative study of immunohistochemistry and fluorescence in situ hybridization of formalin-fixed, paraffin-embedded tissues. Hum Pathol 2002;33:21-28.
25. Thomson TA, Hayes MM, Spinelli JJ, et al. HER-2/neu in breast cancer: interobserver variability and performance of immunohistochemistry with 4 antibodies compared with fluorescent in situ hybridization. Mod Pathol. 2001;14:1079-1086.
26. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
27. Slebos RJ, Evers SG, Wagenaar SS, Rodenhuis S. Cellular protoonocogenes are infrequently amplified in untreated non-small cell lung cancer. Br J Cancer. 1989;59:76-80.
28. Shiraishi M, Noguchi M, Shimosato Y, Sekiya T. Amplification of protooncogenes in surgical specimens of human lung carcinomas. Cancer Res. 1989;49:6474-6479.
29. Kunitomo K, Takehana T, Inoue S, et al. Detection of c-erbB-2 (HER-2/neu) amplification in breast carcinoma by fluorescence in situ hybridization on tissue sections and imprinted cells. Pathol Int. 2002;52:451-457.
30. Sandberg A, Chen, Z. Chromosome abnormalities in solid tumors. In: Mark HFL, editor. Medical cytogenetics. 1st ed. New York: Marcel Dekker, 2000:413-435.
31. Von Hoff DD, McGill JR, Forseth BJ, et al. Elimination of extrachromosomally amplified MYC genes from human tumor cells reduces their tumorigenicity. Proc Natl Acad Sci USA. 1992;89:8165-8169.
32. Slamon DJ, Godolphin W, Jones LA, et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science. 1989;244:707-712.
33. Sheikh MS, Carrier F, Johnson AC, Ogdon SE, Fornace AJ Jr. Identification of an additional p53-responsive site in the human epidermal growth factor receptor gene promoter. Oncogene. 1997;15:1095-1101.
34. Kersting C, Tidow N, Schmidt H, et al. Gene dosage PCR and fluorescence in situ hybridization reveal low frequency of egfr amplifications despite protein overexpression in invasive breast carcinoma. Lab Invest. 2004;84:582-587.
35. McInerney JM, Wilson MA, Strand KJ, Chrysogelos SA. A strong intronic enhancer element of the EGFR gene is preferentially active in high EGFR expressing breast cancer cells. J Cell Biochem. 2001;80:538-549.
36. Gebhardt F, Zanker KS, Brandt B. Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1. J Biol Chem. 1999;274:13176-13180.
37. Meert AP, Martin B, Delmotte P, et al. The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis. Eur Respir J. 2002;20:975-981.
38. Reissmann PT, Koga H, Figlin RA, Holmes EC, Slamon DJ. Amplification and overexpression of the cyclin D1 and epidermal growth factor receptor genes in non-small-cell lung cancer. Lung Cancer Study Group. J Cancer Res Clin Oncol. 1999;125:61-70.
39. Jungbluth AA, Stocken E, Huang HJ, et al. A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor. Proc Natl Acad Sci USA. 2003;100:639-644.
40. Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004;350:2129-2139.